Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Janssen
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 5 ans
A Safety and Efficacy Study of DACOGEN in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia
The primary objectives of the Phase 1 portion of Study DACOGENAML2004 are: •to determine the maximum tolerable dose (MTD) of cytarabine (up to 2 g/m2 per day x 5) that can be administered on Days 8-1...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag S.A
Update Il y a 5 ans
ESTUDIO FASE IV PARA LA EVALUACIÓN DEL EFECTO MODULADOR DE LA GALANTAMINA (REMINYL CLP®) SOBRE EL RITMO CIRCADIANO DE PACIENTES CON ENFERMEDAD DE ALZHEIMER MODERADA
Evaluar el efecto modulador de la galantamina sobre el ritmo circadiano en pacientes con Enfermedad de Alzheimer moderada
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Janssen
Update Il y a 5 ans
Étude 42756493BLC2001 : étude de phase 2, évaluant l’efficacité et la tolérance de deux schémas administration du JNJ-42756493, un inhibiteur de FGFR, chez des patients ayant un cancer urothélial métastatique ou non-résécable chirurgicalement et présentant des altérations génomiques du FGFR. [essai clos aux inclusions]
Etude de phase II, multicentrique, en ouvert, avec 2 bras de traitement, visant à évaluer l'efficacité et la sécurité d’emploi de deux schémas posologiques d’un pan-inhibiteur de la tyrosine kinase de...
Country
France
organs
Appareil urinaire - autres
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 5 ans
An Efficacy and Safety Study of JNJ-42756493 in Participants with Urothelial Cancer
The primary objective of the study is: * To evaluate the objective response rate (complete response [CR]+ partial response [PR]) of the selected dose regimen in subjects with metastatic or surgically...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Janssen-Cilag International N.V
Update Il y a 5 ans
Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007
The primary objective is to demonstrate the safety and tolerability of fulranumab subcutaneous (SC) injections compared with SC placebo, in subjects with standard of care and who have signs and sympto...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Janssen
Update Il y a 5 ans
Étude PLEIADES : étude de phase 2 évaluant l’efficacité du daratumumab en association avec des traitements standards de référence chez des patients ayant un myélome multiple.
Le myélome multiple est une maladie de la moelle osseuse caractérisée par la multiplication dans la moelle osseuse d’un plasmocyte anormal. Le rôle des plasmocytes est de produire les anticorps (immun...
Country
France
organs
Myélomes
Specialty
Immunothérapie - Vaccinothérapie
,
Thérapies Ciblées
,
Chimiothérapie
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Janssen-Cilag International N.V
Update Il y a 5 ans
An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma
The study will evaluate daratumumab separately in three relapsed or refractory NHL subtypes that are CD38 positive: MCL, DLBCL, and FL. There are two main objectives: -To assess overall response rat...
Country
None
organs
None
Specialty
None
unknown
More information
Man
Between 18 years
and 99 years
Janssen
Update Il y a 5 ans
Étude MAGNITUDE : étude de phase 3 randomisée comparant l’efficacité et la tolérance du niraparib associé à l’acétate d’abiratérone et de la prednisone, par rapport à l’acétate d’abiratérone et de la prednisone seuls, chez des patients ayant un cancer de la prostate métastatique et résistant à la castration.
Un cancer de la prostate se développe à partir de cellules de la prostate initialement normales qui se transforment et se multiplient de façon anarchique, jusqu’à former une masse appelée tumeur malig...
Country
France
organs
Prostate
Specialty
Hormonothérapie
,
Thérapies Ciblées
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 5 ans
A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-28431754 (Canagliflozin) Compared with Sitagliptin and Placebo in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy
• To assess the effect of canagliflozin relative to placebo on HbA1c after 26 weeks of treatment • To assess the safety and tolerability of canagliflozin
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag International N.V
Update Il y a 5 ans
An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
The purpose of this study is to assess the efficacy and safety of ustekinumab in adult participants with active nonradiographic axial spondyloarthritis (nr-AxSpA) measured by the reduction in signs an...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
15
16
17
18
19
20
21
22
23
24
Next